Profil bibliographique

Genichiro Ishii

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

493Publications signalées

15232Citations signalées

2Affiliations récentes

Institutions déclarées

Juntendo University National Cancer Center Hospital East

Domaines associés

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentLung Cancer Research StudiesCancer Immunotherapy and BiomarkersCancer Cells and Metastasis

Publications récentes

2026 articleOpenAlex

Neoadjuvant Olaparib and Pembrolizumab Combination Therapy in the Treatment of Patients with HRD-Positive Advanced Ovarian Cancer: A Pilot Study

Kenichi Harano, Takehiro Nakao, Shin Nishio, Takahiro Katsuda et autres

0 citationsClinical Cancer Research

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Table 3 from Lenvatinib Combined with PD-1 Blockade Therapy Benefits Gastric Cancers through Immunosuppressive Macrophage Modulation

Yi-Tzu Lin, Hirotomo Machiyama, Akihito Kawazoe, Atsuo Sai et autres

0 citations

Accès ouvert 2026 otherOpenAlex

Figure S2 from Lenvatinib Combined with PD-1 Blockade Therapy Benefits Gastric Cancers through Immunosuppressive Macrophage Modulation

Yi-Tzu Lin, Hirotomo Machiyama, Akihito Kawazoe, Atsuo Sai et autres

0 citations

Accès ouvert 2026 otherOpenAlex

Data from Lenvatinib Combined with PD-1 Blockade Therapy Benefits Gastric Cancers through Immunosuppressive Macrophage Modulation

Yi-Tzu Lin, Hirotomo Machiyama, Akihito Kawazoe, Atsuo Sai et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Table 4 from Lenvatinib Combined with PD-1 Blockade Therapy Benefits Gastric Cancers through Immunosuppressive Macrophage Modulation

Yi-Tzu Lin, Hirotomo Machiyama, Akihito Kawazoe, Atsuo Sai et autres

0 citations

Accès ouvert 2026 otherOpenAlex

Figure S3 from Lenvatinib Combined with PD-1 Blockade Therapy Benefits Gastric Cancers through Immunosuppressive Macrophage Modulation

Yi-Tzu Lin, Hirotomo Machiyama, Akihito Kawazoe, Atsuo Sai et autres

0 citations

Accès ouvert 2026 otherOpenAlex

Figure S1 from Lenvatinib Combined with PD-1 Blockade Therapy Benefits Gastric Cancers through Immunosuppressive Macrophage Modulation

Yi-Tzu Lin, Hirotomo Machiyama, Akihito Kawazoe, Atsuo Sai et autres

0 citations

Accès ouvert 2026 otherOpenAlex

Figure S7 from Lenvatinib Combined with PD-1 Blockade Therapy Benefits Gastric Cancers through Immunosuppressive Macrophage Modulation

Yi-Tzu Lin, Hirotomo Machiyama, Akihito Kawazoe, Atsuo Sai et autres

0 citations

Accès ouvert 2026 otherOpenAlex

Figure S4 from Lenvatinib Combined with PD-1 Blockade Therapy Benefits Gastric Cancers through Immunosuppressive Macrophage Modulation

Yi-Tzu Lin, Hirotomo Machiyama, Akihito Kawazoe, Atsuo Sai et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Table 2 from Lenvatinib Combined with PD-1 Blockade Therapy Benefits Gastric Cancers through Immunosuppressive Macrophage Modulation

Yi-Tzu Lin, Hirotomo Machiyama, Akihito Kawazoe, Atsuo Sai et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Table 1 from Lenvatinib Combined with PD-1 Blockade Therapy Benefits Gastric Cancers through Immunosuppressive Macrophage Modulation

Yi-Tzu Lin, Hirotomo Machiyama, Akihito Kawazoe, Atsuo Sai et autres

0 citations

Accès ouvert 2026 otherOpenAlex

Figure S5 from Lenvatinib Combined with PD-1 Blockade Therapy Benefits Gastric Cancers through Immunosuppressive Macrophage Modulation

Yi-Tzu Lin, Hirotomo Machiyama, Akihito Kawazoe, Atsuo Sai et autres

0 citations

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.